Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Zimonjic Website

Drazen B. Zimonjic, Ph.D.

Selected Publications

1)  Tripathi V, Popescu NC, Zimonjic DB.
DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.
Oncogene. 33: 724-33, 2014.
[Journal]
2)  Zimonjic DB, Chan LN, Tripathi V, Lu J, Kwon O, Popescu NC, Lowy DR, Tamanoi F.
In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells.
BMC Cancer. 13: 198, 2013.
[Journal]
3)  Tripathi V, Popescu NC, Zimonjic DB.
DLC1 Interaction with α-Catenin Stabilizes Adherens Junctions and Enhances DLC1 Antioncogenic Activity.
Mol. Cell. Biol. 32: 2145-59, 2012.
[Journal]
4)  Zimonjic DB, Popescu NC.
Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics (Review).
International journal of oncology. 2012.
[Journal]
5)  Yang X, Popescu NC, Zimonjic DB.
DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism.
Cancer Res. 71: 2916-25, 2011.
[Journal]
6)  Drgonova J, Zimonjic DB, Hall FS, Uhl GR.
Effect of KEPI (Ppp1r14c) deletion on morphine analgesia and tolerance in mice of different genetic backgrounds: when a knockout is near a relevant quantitative trait locus.
Neuroscience. 165: 882-895, 2010.
[Journal]
7)  Zimonjic DB, Zhou X, Lee JS, Ullmannova-Benson V, Tripathi V, Thorgeirsson SS, Popescu NC.
Acquired genetic and functional alterations associated with transforming growth factor beta type I resistance in Hep3B human hepatocellular carcinoma cell line.
J. Cell. Mol. Med. 2009.
[Journal]
8)  Ullmannova-Benson V, Guan M, Zhou X, Tripathi V, Yang XY, Zimonjic DB, Popescu NC.
DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway.
Leukemia. 23: 383-90, 2009.
[Journal]
9)  Zimonjic DB, Ullmannova-Benson V, Factor VM, Thorgeirsson SS, Popescu NC.
Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease.
Cancer Genet. Cytogenet. 191: 17-26, 2009.
[Journal]
10)  Liu J, Kaur G, Zhawar VK, Zimonjic DB, Popescu NC, Kandpal RP, Athwal RS.
Role of SV40 integration site at chromosomal interval 1q21.1 in immortalized CRL2504 cells.
Cancer Res. 69: 7819-25, 2009.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 2/19/2014.